44
Participants
Start Date
April 30, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
April 30, 2008
MLN8054
"10 mg doses of MLN8054 were given orally once daily following a schedule of 5 days on/2 days off/5 days on repeated every 28 days"
Ciutat Sanitaria Vall d'Hebron, Barcelona
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY